SUZHOU, China, Aug. 2, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that only 13 months after ...
PARIS--(BUSINESS WIRE)--PathoQuest, a leading contract research organization (CRO) for the biosafety testing of biologics with Next-Generation Sequencing (NGS) technologies, today announced that it ...
CROs bring a depth of experience to the process of developing biologics, filling crucial gaps, reducing risks, and getting products to market quickly. This is of particular value to smaller biotech ...
GMP release and stability testing are indispensable elements of the pharmaceutical sector’s quality assurance strategy. These testing protocols not only ensure that pharmaceutical products are safe ...
Enhances drug product services for projects at various stages, with an emphasis on late and commercial stage production Increases up to 60 million vials for commercial drug production per year ...
WUXI and SUZHOU, China, Aug. 1, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that ...
Nanopore sequencing offers a transformational new approach for robust and accurate genetic characterisation of biological materials, enabling the release of novel therapeutics with more certainty and ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
LANCASTER, Pa.--(BUSINESS WIRE)--Eurofins Medical Device Services North America, part of a global network of over 20 medical device testing laboratories and a leading medical device solutions partner, ...
Cytokines are small proteins that serve as the fundamental chemical messengers of the immune system. They also play a key cell signaling role in stem cell biology, relaying messages that direct stem ...
MilliporeSigma, Merck KGaA’s life science business, opened the second phase of its new €29 million ($31.7 million) Biologics Testing Center in China, adding 1,500 m 2 to the lab opened last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback